Preclinical studies indicate that elevated PCSK9 levels following podocyte injury contribute to lipid abnormalities in nephrotic syndrome, while PCSK9 deficiency ameliorates these changes [48,49]. Here, PCSK9 is linked to nephrotic syndrome.